TNS Healthcare
Kantar Health

Presse

Autoren

Hier finden Sie Autorenbeiträge unserer Projektmanager und Berater.


TNS Healthcare Autoren

2009
  • On demand – Different combinations of measures are in place across Europe to control prescribing
    Governments recognise that pharmaceuticals are a cost-effective method of providing treatment to most patients. If the range of reimbursed treatments is too narrow or the cost to the patient too high, there will be public health repercussions and an increase in costly hospital admissions. Demand for pharmaceuticals is regulated by efforts to influence prescribers and by co-payments and these affect both doctors’ and patients’ willingness
    to use a particularly therapy.
    By Susanne Michel. In Pharmaceutical Marketing Europe, July / August 2009
  • Ansehen der Pharmaunternehmen hat bei Ärzten gelitten
    In den Augen der deutschen Allgemeinmediziner und Internisten ist sowohl die Performance als auch die Qualität und Wertigkeit der von großen Pharmafirmen angebotenen Leistungen in den letzten zwei Jahren zurückgegangen.
    Von Oliver Feiler. Erschienen im PM-Report 05/09.
  • Controlling Supply: Increasing the Efficiency of Healthcare Spend to Counter Spiraling Expenditures
    Over the past 15 years, national authorities in Europe have implemented controls and incentives to influence supply and demand of pharmaceuticals. Some countries continue to put greater emphasis on regulating supply, although most now are also increasing their focus on controlling demand. Both measures are needed to counter spiralling healthcare expenditure.
    By Susanne Michel. In Pharmaceutical Marketing Europe.
  • How can Marketing and Brand Performance Generate a Competitive Edge?
    Pharmaceutical Marketing is undergoing a fundamental transformation as it adapts to new trends. These changes are providing fresh opportunities for market research to contribute to brand success. By pursuing a more holistic approach - one that inlcudes new market and brand factors in its analysis - market research can help brand managers gain a competitive edge.
    By Anja Romaus. In PM 360.
  • Optimizing Market Access in Emerging Countries
    As pharmaceutical companies scan for new growth opportunities over the next
    decade, they are finding the most promising in the world’s emerging economies.
    By Dr. Susanne Michel. In PBIRG Perspective Newsletter.
2008
  • Wie man mit Markt- und Markenforschung Wettbewerbsvorteile generieren kann
    Neue Chancen für die Marktforschung.
    Anja Romaus, Pharma Relations, August 2008, Bonn
  • Besser als der Ruf
    Ein Baustein der neuen Strategien der Pharmaunternehmen istdie Ausrichtung hin zu mehr Customer-Service-Management. Doch wie kommt die Außendienst-Performance beim Kunden – dem Arzt – an? Ein Sechs-Ländervergleich von TNS Healthcare.
    Siegfried Ertl,Tobias Reiland, Pharma Marketing Journal 3-2008, Juli 2008, Düsseldorf
  • Patientenverhalten in 6 europäischen Ländern
    Ein Blick auf Patienten in den verschiedenen Gesundheitssystemen
    Dr. Peter Potthoff, Hedi Mühlbauer, Jahrbuch Healthcare Marketing 2008, Hamburg
2007